Corcept Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Corcept Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2008-12-31 | 2006-12-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 102,745,000 | 89,819,000 | 127,665,000 | 137,289,000 | 128,588,000 | 149,750,000 | 135,551,000 | 111,800,000 | 172,377,000 | 299,942,000 | 66,329,000 | 50,243,000 | 35,346,000 | 61,862,000 | 77,617,000 | 94,688,000 | 95,430,000 | 52,381,000 | 76,190,000 | 30,560,000 | 58,523,000 | 84,477,000 | 31,269,000 | 44,948,000 | 58,141,000 | 49,650,000 | 41,625,000 | 33,894,000 | 31,165,000 | 33,121,000 | 31,062,000 | 31,060,000 | 33,623,000 | 37,976,000 | 51,536,000 | 47,865,000 | 41,789,000 | 40,744,000 | 40,435,000 | 36,450,000 | 37,048,000 | 37,953,000 | 24,248,000 | 26,780,000 | 33,974,000 | 43,618,000 | 54,877,000 | 63,175,000 | 72,220,000 | 81,460,000 | 93,032,000 | 101,628,000 | 34,899,000 | 42,627,000 | 45,909,000 | 52,230,000 | 59,201,000 | 24,578,000 | 28,976,000 | 35,385,000 | 18,548,000 | 10,716,000 | 14,716,000 | 8,906,000 | 3,816,000 | 1,412,000 | 2,826,000 | 3,501,000 | 5,930,117 | 8,993,337 |
| short-term marketable securities | 239,481,000 | 232,944,000 | 255,669,000 | 243,047,000 | 344,568,000 | 261,011,000 | 232,670,000 | 243,425,000 | 190,885,000 | 165,115,000 | 365,343,000 | 346,019,000 | 334,740,000 | 283,665,000 | 145,918,000 | 266,643,000 | 274,552,000 | 320,578,000 | 364,506,000 | 398,233,000 | 346,835,000 | 222,838,000 | 244,693,000 | 186,697,000 | 143,396,000 | 137,255,000 | 165,135,000 | 161,300,000 | 128,780,000 | 92,241,000 | 57,682,000 | 44,096,000 | 32,542,000 | 14,798,000 | ||||||||||||||||||||||||||||||||||||
| trade receivables, net of allowance | 64,567,000 | 61,819,000 | 53,976,000 | 59,717,000 | 53,837,000 | 61,518,000 | 41,123,000 | 34,626,000 | 32,553,000 | 32,557,000 | 31,057,000 | 29,414,000 | 28,164,000 | 27,178,000 | 27,625,000 | 26,508,000 | 27,620,000 | 22,200,000 | 26,198,000 | 21,957,000 | 22,725,000 | 26,684,000 | 19,928,000 | 22,405,000 | 19,774,000 | 19,218,000 | 17,588,000 | 19,360,000 | 28,704,000 | 17,261,000 | 15,300,000 | 11,872,000 | 9,504,000 | 9,214,000 | 9,860,000 | |||||||||||||||||||||||||||||||||||
| inventory | 12,276,000 | 14,368,000 | 12,412,000 | 8,050,000 | 8,350,000 | 7,190,000 | 7,730,000 | 7,513,000 | 6,915,000 | 6,409,000 | 6,100,000 | 6,046,000 | 5,437,000 | 5,079,000 | 4,988,000 | 4,994,000 | 4,669,000 | 4,948,000 | 4,910,000 | 4,817,000 | 4,927,000 | 5,084,000 | 5,424,000 | 5,462,000 | 5,142,000 | 5,000,000 | 4,732,000 | 5,362,000 | 4,947,000 | 4,876,000 | 4,576,000 | 3,828,000 | 3,089,000 | 2,888,000 | 2,329,000 | 2,327,000 | 2,134,000 | 1,912,000 | 1,682,000 | 1,604,000 | 1,451,000 | 1,310,000 | 1,207,000 | 1,080,000 | 1,072,000 | 1,127,000 | 1,096,000 | 1,025,000 | 694,000 | 1,026,000 | 853,000 | 1,837,000 | 2,437,000 | 56,000 | ||||||||||||||||
| prepaid expenses and other current assets | 24,043,000 | 39,553,000 | 21,880,000 | 18,875,000 | 25,503,000 | 23,898,000 | 27,562,000 | 20,163,000 | 15,858,000 | 15,870,000 | 16,424,000 | 20,680,000 | 15,358,000 | 10,436,000 | 10,315,000 | 9,067,000 | 8,999,000 | 9,517,000 | 6,697,000 | 7,926,000 | 5,323,000 | 5,693,000 | 6,044,000 | 7,798,000 | 6,202,000 | 5,741,000 | 7,740,000 | 4,275,000 | 3,579,000 | 3,324,000 | 2,669,000 | 3,086,000 | 2,527,000 | 1,799,000 | 1,964,000 | 1,353,000 | 1,554,000 | 1,106,000 | 642,000 | 1,180,000 | 1,241,000 | 622,000 | 1,441,000 | 1,769,000 | 2,166,000 | 1,453,000 | 910,000 | 1,004,000 | 801,000 | 572,000 | 620,000 | 800,000 | 608,000 | 102,000 | 427,000 | 455,000 | 604,000 | 418,000 | 613,000 | 621,000 | 581,000 | 686,000 | 1,270,000 | 343,000 | 425,000 | 830,000 | 1,317,000 | 797,000 | 838,114 | 347,940 |
| total current assets | 443,112,000 | 438,503,000 | 471,602,000 | 466,978,000 | 560,846,000 | 503,367,000 | 458,636,000 | 431,527,000 | 432,588,000 | 533,893,000 | 499,253,000 | 452,402,000 | 419,045,000 | 388,220,000 | 266,463,000 | 401,900,000 | 411,270,000 | 409,624,000 | 478,501,000 | 463,493,000 | 438,333,000 | 344,776,000 | 307,358,000 | 267,310,000 | 232,655,000 | 216,864,000 | 236,820,000 | 224,191,000 | 197,175,000 | 150,823,000 | 124,185,000 | 93,942,000 | 81,285,000 | 66,675,000 | 65,689,000 | 59,781,000 | 54,778,000 | 50,514,000 | 48,980,000 | 45,179,000 | 44,691,000 | 44,186,000 | 30,230,000 | 32,375,000 | 39,437,000 | 48,120,000 | 58,311,000 | 66,223,000 | 74,570,000 | 84,201,000 | 95,062,000 | 104,619,000 | 38,299,000 | 42,785,000 | 46,336,000 | 52,685,000 | 59,805,000 | 24,996,000 | 29,589,000 | 36,006,000 | 19,129,000 | 11,402,000 | 19,579,000 | 9,799,000 | 29,505,000 | 30,641,000 | 33,655,000 | 33,077,000 | 38,239,247 | 9,341,277 |
| strategic inventory | 7,991,000 | 1,166,000 | 3,583,000 | 7,764,000 | 8,451,000 | 7,846,000 | 8,244,000 | 8,752,000 | 8,762,000 | 10,156,000 | 10,931,000 | 11,027,000 | 11,978,000 | 13,098,000 | 12,962,000 | 13,659,000 | 14,734,000 | 15,384,000 | 16,247,000 | 12,075,000 | 11,193,000 | 11,063,000 | 11,981,000 | 11,539,000 | 12,726,000 | 10,360,000 | 11,510,000 | 7,360,000 | 5,500,000 | 2,910,000 | 3,800,000 | 1,680,000 | 3,210,000 | 3,820,000 | 2,835,000 | 2,980,000 | 1,960,000 | 2,280,000 | 2,800,000 | 2,990,000 | 3,420,000 | 3,730,000 | 4,090,000 | 4,430,000 | 4,570,000 | 4,330,000 | 4,450,000 | 4,530,000 | 4,850,000 | 3,650,000 | 3,810,000 | 640,000 | ||||||||||||||||||
| operating lease right-of-use asset | 4,964,000 | 5,147,000 | 5,324,000 | 5,503,000 | 5,684,000 | 61,000 | 120,000 | 178,000 | 235,000 | 575,000 | 1,143,000 | 1,707,000 | 2,264,000 | 2,816,000 | 514,000 | 1,022,000 | 1,524,000 | 2,020,000 | 2,509,000 | 2,993,000 | 3,472,000 | 3,082,000 | 3,446,000 | 742,000 | 1,106,000 | 1,465,000 | ||||||||||||||||||||||||||||||||||||||||||||
| property and equipment | 2,348,000 | 2,543,000 | 2,689,000 | 2,930,000 | 1,472,000 | 127,000 | 302,000 | 413,000 | 461,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term marketable securities | 172,775,000 | 248,041,000 | 219,831,000 | 167,310,000 | 19,315,000 | 40,276,000 | 57,176,000 | 59,621,000 | 4,947,000 | 4,895,000 | 11,890,000 | 22,566,000 | 112,277,000 | 133,845,000 | 101,657,000 | 81,834,000 | 36,196,000 | 15,425,000 | 4,200,000 | 41,690,000 | 39,352,000 | 35,250,000 | 24,165,000 | 28,842,000 | 1,481,000 | 15,010,000 | 15,281,000 | 1,508,000 | 1,494,000 | 4,493,000 | ||||||||||||||||||||||||||||||||||||||||
| other assets | 8,303,000 | 6,610,000 | 6,610,000 | 6,973,000 | 6,939,000 | 6,388,000 | 6,541,000 | 6,540,000 | 4,413,000 | 4,764,000 | 5,058,000 | 5,081,000 | 1,834,000 | 2,984,000 | 3,083,000 | 4,106,000 | 4,140,000 | 5,030,000 | 5,000,000 | 5,010,000 | 4,536,000 | 3,441,000 | 3,448,000 | 150,000 | 150,000 | 75,000 | 50,000 | 53,000 | 53,000 | 73,000 | 50,000 | 12,989,000 | 49,000 | 49,000 | 24,000 | 24,000 | 24,000 | 25,000 | 59,000 | 65,000 | 71,000 | 78,000 | 74,000 | 81,000 | 87,000 | 96,000 | 113,000 | 120,000 | 128,000 | 136,000 | 144,000 | 160,000 | 260,000 | 72,000 | 40,000 | 32,000 | 28,000 | 104,000 | 95,000 | 86,000 | 80,000 | 206,000 | 176,000 | 65,000 | 60,000 | 76,000 | 83,000 | 51,000 | 46,858 | 941,678 |
| deferred tax assets | 162,229,000 | 144,445,000 | 130,914,000 | 126,799,000 | 111,848,000 | 97,870,000 | 90,605,000 | 87,102,000 | 78,214,000 | 67,999,000 | 61,465,000 | 57,342,000 | 48,491,000 | 37,713,000 | 27,455,000 | 29,641,000 | 33,741,000 | 37,025,000 | 31,603,000 | 33,818,000 | 35,470,000 | 40,562,000 | 45,677,000 | 50,804,000 | 56,700,000 | 61,681,000 | 62,659,000 | 66,126,000 | 71,102,000 | 73,583,000 | 76,703,000 | |||||||||||||||||||||||||||||||||||||||
| total assets | 801,722,000 | 846,455,000 | 840,553,000 | 784,257,000 | 714,555,000 | 655,935,000 | 621,517,000 | 594,022,000 | 524,625,000 | 617,848,000 | 583,430,000 | 533,255,000 | 496,364,000 | 468,123,000 | 423,756,000 | 585,399,000 | 568,480,000 | 552,398,000 | 571,731,000 | 534,125,000 | 497,823,000 | 445,494,000 | 412,312,000 | 367,022,000 | 328,679,000 | 320,212,000 | 311,694,000 | 299,751,000 | 274,382,000 | 242,976,000 | 220,537,000 | 110,672,000 | 86,537,000 | 75,339,000 | 68,753,000 | 62,930,000 | 56,838,000 | 52,912,000 | 51,937,000 | 48,377,000 | 48,355,000 | 48,224,000 | 34,630,000 | 37,159,000 | 44,390,000 | 52,831,000 | 63,077,000 | 71,057,000 | 79,687,000 | 88,141,000 | 99,166,000 | 105,524,000 | 38,618,000 | 42,887,000 | 46,379,000 | 52,720,000 | 59,837,000 | 25,104,000 | 29,688,000 | 36,097,000 | 19,216,000 | 11,620,000 | 19,775,000 | 9,902,000 | 30,156,000 | 34,321,000 | 38,135,000 | 41,929,000 | 47,771,628 | 10,282,955 |
| liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 23,525,000 | 27,947,000 | 15,376,000 | 18,584,000 | 19,484,000 | 12,557,000 | 17,396,000 | 16,710,000 | 7,976,000 | 11,216,000 | 11,976,000 | 8,178,000 | 8,246,000 | 9,269,000 | 6,908,000 | 6,558,000 | 9,216,000 | 6,969,000 | 10,554,000 | 6,510,000 | 6,304,000 | 4,976,000 | 7,537,000 | 5,937,000 | 7,026,000 | 9,330,000 | 8,266,000 | 13,922,000 | 6,365,000 | 7,850,000 | 8,579,000 | 6,226,000 | 2,082,000 | 4,253,000 | 2,290,000 | 4,309,000 | 2,081,000 | 2,082,000 | 1,325,000 | 1,740,000 | 2,360,000 | 1,036,000 | 1,886,000 | 1,960,000 | 2,595,000 | 3,666,000 | 2,381,000 | 2,337,000 | 3,033,000 | 2,263,000 | 3,804,000 | 1,574,000 | 4,235,000 | 2,084,000 | 1,066,000 | 2,291,000 | 1,865,000 | 817,000 | 1,677,000 | 1,173,000 | 1,023,000 | 892,000 | 1,304,000 | 916,000 | 549,000 | 833,000 | 125,000 | 285,000 | 549,516 | 935,788 |
| accrued research and development expenses | 29,049,000 | 25,260,000 | 33,868,000 | 27,736,000 | 21,972,000 | 24,825,000 | 21,330,000 | 21,305,000 | 18,607,000 | 13,981,000 | 14,573,000 | 13,771,000 | 13,803,000 | 13,051,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued and other liabilities | 91,073,000 | 88,875,000 | 90,700,000 | 79,464,000 | 59,250,000 | 59,744,000 | 51,628,000 | 69,633,000 | 52,179,000 | 39,093,000 | 30,799,000 | 29,412,000 | 24,744,000 | 32,660,000 | 27,665,000 | 24,309,000 | 21,514,000 | 17,999,000 | 21,186,000 | 18,972,000 | 22,631,000 | 19,590,000 | 23,269,000 | 21,568,000 | 16,437,000 | |||||||||||||||||||||||||||||||||||||||||||||
| short-term operating lease liability | 1,017,000 | 984,000 | 829,000 | 432,000 | 44,000 | 76,000 | 151,000 | 225,000 | 297,000 | 575,000 | 1,143,000 | 1,707,000 | 2,264,000 | 2,264,000 | 526,000 | 1,046,000 | 1,559,000 | 2,067,000 | 2,050,000 | 2,034,000 | 2,019,000 | 1,571,000 | 1,558,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| total current liabilities | 144,664,000 | 143,066,000 | 140,773,000 | 126,216,000 | 100,750,000 | 97,202,000 | 104,505,000 | 121,873,000 | 93,059,000 | 78,865,000 | 72,491,000 | 53,068,000 | 49,057,000 | 57,244,000 | 47,541,000 | 44,757,000 | 45,402,000 | 40,601,000 | 47,494,000 | 43,048,000 | 42,243,000 | 34,075,000 | 38,841,000 | 32,396,000 | 30,381,000 | 34,218,000 | 35,573,000 | 40,206,000 | 30,873,000 | 27,749,000 | 29,569,000 | 24,370,000 | 20,392,000 | 25,759,000 | 27,374,000 | 31,683,000 | 27,434,000 | 24,025,000 | 20,876,000 | 18,767,000 | 17,430,000 | 15,526,000 | 13,555,000 | 12,486,000 | 13,302,000 | 15,242,000 | 12,738,000 | 10,142,000 | 9,079,000 | 8,243,000 | 8,359,000 | 5,548,000 | 5,816,000 | 3,570,000 | 2,713,000 | 3,856,000 | 3,196,000 | 3,860,000 | 2,993,000 | 2,859,000 | 2,143,000 | 2,358,000 | 2,862,000 | 3,513,000 | 3,521,000 | 2,656,000 | 1,503,000 | 1,261,000 | 1,824,041 | 1,529,567 |
| long-term operating lease liability | 5,588,000 | 5,851,000 | 6,107,000 | 6,359,000 | 5,625,000 | 552,000 | 501,000 | 997,000 | 1,486,000 | 1,541,000 | 1,903,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term accrued income taxes payable | 15,677,000 | 14,253,000 | 14,084,000 | 12,847,000 | 11,937,000 | 10,869,000 | 10,307,000 | 10,470,000 | 9,952,000 | 9,399,000 | 9,097,000 | 6,823,000 | 4,981,000 | 2,516,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities | 165,929,000 | 163,170,000 | 160,964,000 | 145,422,000 | 118,312,000 | 108,071,000 | 114,812,000 | 132,343,000 | 103,011,000 | 88,264,000 | 81,588,000 | 59,891,000 | 54,038,000 | 60,312,000 | 47,950,000 | 45,170,000 | 45,805,000 | 41,596,000 | 48,393,000 | 44,445,000 | 44,125,000 | 36,005,000 | 41,130,000 | 32,646,000 | 30,626,000 | 34,457,000 | 35,812,000 | 2,868,000 | 3,542,000 | 3,563,000 | 2,701,000 | 1,513,000 | 1,824,041 | 2,058,464 | ||||||||||||||||||||||||||||||||||||
| commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 138,000 | 137,000 | 136,000 | 135,000 | 134,000 | 133,000 | 133,000 | 133,000 | 132,000 | 131,000 | 131,000 | 130,000 | 128,000 | 128,000 | 127,000 | 126,000 | 125,000 | 124,000 | 122,000 | 121,000 | 121,000 | 120,000 | 120,000 | 119,000 | 118,000 | 118,000 | 117,000 | 116,000 | 116,000 | 115,000 | 115,000 | 114,000 | 113,000 | 113,000 | 113,000 | 111,000 | 110,000 | 110,000 | 110,000 | 109,000 | 108,000 | 108,000 | 101,000 | 101,000 | 101,000 | 101,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 89,000 | 89,000 | 84,000 | 84,000 | 84,000 | 72,000 | 72,000 | 72,000 | 63,000 | 50,000 | 50,000 | 26,000 | 23,000 | 23,000 | 23,000 | 23,000 | 9,335 | |
| treasury stock | -866,931,000 | -744,692,000 | -696,173,000 | -682,177,000 | -650,763,000 | -641,059,000 | -635,078,000 | -631,788,000 | -614,074,000 | -462,507,000 | -456,148,000 | -453,001,000 | -426,814,000 | -417,448,000 | -410,411,000 | -194,304,000 | -164,263,000 | -131,855,000 | -75,795,000 | -63,969,000 | -63,814,000 | -62,979,000 | -62,704,000 | -59,732,000 | -59,732,000 | -42,312,000 | -23,657,000 | -8,904,000 | ||||||||||||||||||||||||||||||||||||||||||
| additional paid-in capital | 900,864,000 | 862,866,000 | 832,108,000 | 806,317,000 | 781,012,000 | 758,244,000 | 738,515,000 | 722,397,000 | 695,718,000 | 679,848,000 | 662,342,000 | 648,831,000 | 625,976,000 | 608,717,000 | 591,349,000 | 571,377,000 | 554,154,000 | 536,363,000 | 516,140,000 | 496,489,000 | 481,714,000 | 465,528,000 | 457,060,000 | 446,611,000 | 436,622,000 | 427,317,000 | 417,228,000 | 408,154,000 | 401,011,000 | 390,951,000 | 384,074,000 | 377,678,000 | 371,282,000 | 367,359,000 | 363,534,000 | 358,001,000 | 355,000,000 | 350,485,000 | 348,796,000 | 344,735,000 | 342,184,000 | 339,294,000 | 320,511,000 | 318,687,000 | 317,449,000 | 315,817,000 | 313,534,000 | 312,166,000 | 310,858,000 | 309,593,000 | 308,283,000 | 307,033,000 | 259,901,000 | 258,820,000 | 242,209,000 | 240,973,000 | 239,921,000 | 197,473,000 | 195,831,000 | 195,269,000 | 173,418,000 | 154,381,000 | 153,031,000 | 105,125,000 | 101,014,000 | 101,027,000 | 101,006,000 | 101,334,000 | 101,360,621 | 10,428,765 |
| accumulated other comprehensive income | 2,291,000 | 692,000 | -217,000 | 1,571,000 | 84,000 | 258,000 | 609,000 | 45,000 | 115,000 | 215,000 | 249,000 | 577,000 | 840,000 | 310,000 | -1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| retained earnings | 599,431,000 | 564,282,000 | 543,735,000 | 512,989,000 | 465,776,000 | 430,288,000 | 402,526,000 | 371,171,000 | 339,793,000 | 312,265,000 | 296,386,000 | 279,785,000 | 245,177,000 | 217,765,000 | 194,968,000 | 162,915,000 | 132,444,000 | 105,921,000 | 82,456,000 | 56,462,000 | 34,837,000 | 6,510,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 635,793,000 | 683,285,000 | 679,589,000 | 638,835,000 | 596,243,000 | 547,864,000 | 506,705,000 | 461,679,000 | 421,614,000 | 529,584,000 | 501,842,000 | 473,364,000 | 442,326,000 | 407,811,000 | 375,806,000 | 540,229,000 | 522,675,000 | 510,802,000 | 523,338,000 | 489,680,000 | 453,698,000 | 409,489,000 | 371,182,000 | 334,376,000 | 298,053,000 | 285,755,000 | 275,882,000 | 259,545,000 | 243,509,000 | 215,227,000 | 190,968,000 | 86,302,000 | 66,145,000 | 49,580,000 | 41,379,000 | 31,247,000 | 25,660,000 | 20,168,000 | 18,498,000 | 13,477,000 | 11,526,000 | 10,572,000 | -3,388,000 | -1,317,000 | 3,452,000 | 9,371,000 | 21,017,000 | 30,773,000 | 40,371,000 | 51,003,000 | 61,777,000 | 71,651,000 | 32,802,000 | 39,317,000 | 43,666,000 | 48,864,000 | 56,641,000 | 21,244,000 | 26,695,000 | 33,238,000 | 17,073,000 | 9,262,000 | 16,907,000 | 6,360,000 | 26,593,000 | 31,620,000 | 36,622,000 | 40,668,000 | 45,947,587 | -33,491,483 |
| total liabilities and stockholders’ equity | 801,722,000 | 846,455,000 | 840,553,000 | 784,257,000 | 714,555,000 | 655,935,000 | 621,517,000 | 594,022,000 | 524,625,000 | 617,848,000 | 583,430,000 | 533,255,000 | 496,364,000 | 468,123,000 | 423,756,000 | 585,399,000 | 568,480,000 | 552,398,000 | 571,731,000 | 534,125,000 | 497,823,000 | 445,494,000 | 412,312,000 | 367,022,000 | 328,679,000 | 320,212,000 | 311,694,000 | 299,751,000 | 274,382,000 | 242,976,000 | 220,537,000 | 110,672,000 | 86,537,000 | 75,339,000 | 68,753,000 | 62,930,000 | 56,838,000 | 52,912,000 | 51,937,000 | 48,377,000 | 48,355,000 | 48,224,000 | 34,630,000 | 37,159,000 | 44,390,000 | 52,831,000 | 63,077,000 | 71,057,000 | 79,687,000 | 88,141,000 | 99,166,000 | 105,524,000 | 38,618,000 | 42,887,000 | 46,379,000 | 52,720,000 | 59,837,000 | 25,104,000 | 29,688,000 | 36,097,000 | 19,216,000 | 11,620,000 | 19,775,000 | 9,902,000 | 30,156,000 | 34,321,000 | 38,135,000 | 41,929,000 | 47,771,628 | 10,282,955 |
| insurance recovery receivable related to melucci litigation | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued settlement related to melucci litigation | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding as of december 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation and amortization | 195,000 | 633,000 | 801,000 | 862,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding as of december 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -234,000 | -153,000 | -869,000 | -2,381,000 | -2,141,000 | -1,351,000 | -70,000 | -77,000 | -127,000 | -152,000 | -75,000 | -14,000 | -17,000 | -12,000 | -108,000 | -120,000 | -106,000 | -152,000 | -61,734 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding as of december 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation | 726,000 | 1,002,000 | 1,226,000 | 1,414,000 | 1,481,000 | 1,675,000 | 1,311,000 | 619,000 | 880,000 | 1,050,000 | 1,227,000 | 1,177,000 | 925,000 | 655,000 | 540,000 | 552,000 | 577,000 | 518,000 | 553,000 | 499,000 | 302,000 | 205,000 | 145,000 | 76,000 | 93,000 | 98,000 | 143,000 | 173,000 | 230,000 | 236,000 | 273,000 | 296,000 | 285,000 | 203,000 | 184,000 | 139,000 | 154,000 | 150,000 | 105,000 | 59,000 | 30,000 | 3,000 | 3,000 | 4,000 | 4,000 | 4,000 | 5,000 | 7,000 | 12,000 | 20,000 | 38,000 | 52,000 | 55,000 | 50,000 | ||||||||||||||||
| accrued clinical expenses | 12,442,000 | 12,844,000 | 13,113,000 | 13,566,000 | 13,704,000 | 15,532,000 | 11,289,000 | 7,938,000 | 6,477,000 | 4,121,000 | 5,770,000 | 4,537,000 | 3,521,000 | 5,392,000 | 5,397,000 | 3,486,000 | 2,247,000 | 1,892,000 | 1,511,000 | 1,461,000 | 1,467,000 | 1,775,000 | 963,000 | 1,094,000 | 1,171,000 | 609,000 | 492,000 | 1,358,000 | 336,000 | 276,000 | 1,643,000 | 3,380,000 | 3,288,000 | 1,963,000 | 1,044,000 | 583,000 | 843,000 | 605,000 | 640,000 | 781,000 | 755,000 | 799,000 | 694,000 | 815,000 | 851,000 | 1,123,000 | 692,000 | 955,000 | 989,000 | 2,224,000 | 2,521,000 | 1,426,000 | 961,000 | 596,000 | 655,488 | 209,127 | ||||||||||||||
| long-term accrued income taxes | 409,000 | 413,000 | 403,000 | 995,000 | 398,000 | 400,000 | 396,000 | 389,000 | 386,000 | 250,000 | 245,000 | 239,000 | 239,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive gain | -227,000 | 415,000 | 261,000 | 314,000 | 321,000 | 94,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2020 and december 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2019 and december 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated deficit | -23,555,000 | -52,936,000 | -79,276,000 | -99,462,000 | -117,736,000 | -139,744,000 | -157,491,000 | -175,687,000 | -193,146,000 | -291,476,000 | -305,233,000 | -317,880,000 | -322,268,000 | -326,865,000 | -329,450,000 | -330,427,000 | -330,408,000 | -331,367,000 | -330,766,000 | -328,830,000 | -324,000,000 | -320,105,000 | -314,098,000 | -306,547,000 | -292,617,000 | -281,493,000 | -270,587,000 | -258,690,000 | -246,606,000 | |||||||||||||||||||||||||||||||||||||||||
| operating lease liability | 770,000 | 1,148,000 | 1,521,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other accrued liabilities | 18,830,000 | 23,786,000 | 20,892,000 | 19,111,000 | 16,413,000 | 18,743,000 | 16,252,000 | 12,226,000 | 9,938,000 | 8,953,000 | 6,874,000 | 5,833,000 | 4,527,000 | 3,257,000 | 2,832,000 | 2,507,000 | 2,419,000 | 1,876,000 | 1,539,000 | 1,624,000 | 1,271,000 | 1,301,000 | 777,000 | 812,000 | 958,000 | 695,000 | 786,000 | 621,000 | 441,000 | 660,000 | 552,000 | 410,000 | 252,000 | 344,000 | 199,000 | 288,000 | 397,000 | 417,000 | 380,000 | 619,037 | 384,652 | |||||||||||||||||||||||||||||
| other receivable | 12,896,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2018 and december 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt obligation - current portion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term obligation - current portion | 4,573,000 | 10,107,000 | 14,664,000 | 18,725,000 | 18,557,000 | 16,322,000 | 13,507,000 | 12,034,000 | 10,658,000 | 9,424,000 | 8,661,000 | 7,396,000 | 6,896,000 | 5,743,000 | 2,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at september 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| commitments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at june 30, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at march 31, 2017 and december 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 158,000 | 79,000 | 37,000 | 55,000 | 33,000 | 50,000 | 44,000 | 29,000 | 25,000 | 55,000 | 37,000 | 76,000 | 16,000 | 21,000 | 26,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term obligation, net of current portion | 3,744,000 | 8,719,000 | 12,563,000 | 16,133,000 | 19,399,000 | 22,126,000 | 24,463,000 | 25,990,000 | 27,636,000 | 28,218,000 | 29,322,000 | 30,142,000 | 30,237,000 | 28,895,000 | 29,030,000 | 28,325,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at december 31, 2016 and december 31, 2015 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| trade receivables | 8,236,000 | 9,301,000 | 6,752,000 | 6,221,000 | 5,945,000 | 4,951,000 | 4,301,000 | 3,334,000 | 2,746,000 | 2,225,000 | 1,922,000 | 1,428,000 | 1,019,000 | 855,000 | 1,143,000 | 557,000 | 354,000 | 355,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term obligation – current portion | 14,965,000 | 3,650,000 | 3,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2015 and 2014 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2014 and 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at september 30, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at june 30, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at march 31, 2014 and december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2013 or 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accrued compensation | 510,000 | 503,000 | 463,000 | 351,000 | 312,000 | 294,000 | 264,000 | 232,000 | 214,000 | 227,000 | 1,806,000 | 213,000 | 219,000 | 225,000 | 214,000 | 243,000 | 138,000 | 144,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term obligation—current portion | 4,500,000 | 2,650,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at september 30, 2013 and december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at june 30, 2013 and december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value 0.001 per share, 10,000 shares authorized and no shares outstanding at march 31, 2013 and december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2012 or 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated deficit and comprehensive loss | -235,482,000 | -227,188,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deficit accumulated during the development stage | -219,592,000 | -198,622,000 | -192,187,000 | -183,305,000 | -176,204,000 | -169,111,000 | -162,006,000 | -156,311,000 | -145,068,000 | -130,072,000 | -98,438,000 | -73,565,000 | -68,318,000 | -63,095,000 | -58,984,000 | -53,471,907 | -40,488,355 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| notes receivable from stockholders | -5,000 | -6,000 | -59,000 | -97,000 | -97,000 | -97,000 | -97,000 | -101,000 | -6,101,000 | -125,000 | -168,000 | -184,000 | -184,000 | -184,000 | -183,841 | -246,258 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| obligations under capital lease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other liabilities | 422,000 | 316,000 | 222,000 | 295,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2010 or 2009 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| obligations under capital lease, short-term | 4,000 | 9,000 | 10,000 | 13,000 | 12,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| short-term investments | 3,593,000 | 550,000 | 25,264,000 | 28,399,000 | 29,512,000 | 28,779,000 | 31,471,016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| obligations under capital lease, long-term | 6,000 | 29,000 | 42,000 | 45,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2008 or 2007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred compensation | -228,000 | -603,000 | -808,000 | -1,022,000 | -1,369,000 | -1,718,246 | -3,194,970 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term investments | 539,000 | 3,549,000 | 4,347,000 | 8,801,000 | 9,485,523 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2006 or 2005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 10,000 shares authorized and no shares outstanding at december 31, 2005 or 2004 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, undesignated: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10,000,000 shares authorized; no shares outstanding at december 31, 2004 or march 31, 2005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible note payable | 528,897 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 0.001 par value, issuable in series; 10,000,000 shares authorized; 6,768,558 shares issued and outstanding at december 31, 2003; no shares outstanding at december 31, 2004 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock, 0.001 par value, issuable in series; 10,000,000 shares authorized and 6,768,558 shares issued and outstanding at december 31, 2003 and march 31, 2004; aggregate liquidation preference of 41,702,203 at march 31, 2004 | 41,715,974 |
We provide you with 20 years of balance sheets for Corcept Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Corcept Therapeutics. Explore the full financial landscape of Corcept Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about Corcept Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.